Scott Chadderdon MD
Adult Congenital Heart Disease, Echocardiography, Non-Invasive Cardiology
Assistant Professor, Medicine, Oregon Health and Science University School of Medicine
Join to View Full Profile
3181 Sw Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-8750
Dr. Chadderdon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Cardiovascular Disease, 2006 - 2009- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2002 - 2005
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2002
Certifications & Licensure
OR State Medical License 2004 - 2025
WA State Medical License 2005 - 2012
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Physical Activity and Obesity Start of enrollment: 2014 Feb 01
- 2019-06 TRISCEND Study Start of enrollment: 2020 May 06
Publications & Presentations
PubMed
- Transcatheter-Edge-to-Edge-Repair for Severe Tricuspid Regurgitation: Have We Found the "Sweet Spot"?Firas Zahr, Scott M Chadderdon
JACC. Cardiovascular Interventions. 2025-02-10 - Residual Mitral Regurgitation Interacts With Transmitral Mean Pressure Gradient to Modify the Association With Mortality Following Transcatheter Edge-to-Edge Repair.Neal M Duggal, Milo Engoren, Paul Sorajja, D Scott Lim, Jason H Rogers
Circulation. Cardiovascular Interventions. 2025-02-01 - 8 citationsQuality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial.Suzanne V Arnold, Rebecca T Hahn, Vinod H Thourani, Raj Makkar, Moody Makar
Journal of the American College of Cardiology. 2025-01-28
Press Mentions
Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival BenefitFebruary 12th, 2025- TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TROctober 29th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
